Peanut

Australia, the ‘allergy capital of the world,’ has launched a world-first free nationwide treatment program for children with peanut allergies. The goal is to safely build tolerance so that kids don’t need to worry about the possibility of a life-threatening reaction.

Researchers have found that administering under-the-tongue immunotherapy given to young peanut-allergic children is a safe and effective way of desensitizing them to the food. It may provide another method of curbing this potentially deadly allergy.

Ever dropped a peanut in a glass of beer? If not, researchers say you're missing out, as it triggers an unusual interaction that temporarily defies the principle of buoyancy. We believe the hypothesis was rigorously tested with repeat experiments.

While three million Americans suffer from a nut allergy, there's little in the way of medical intervention. But in a world first, researchers have taken a cue from the pandemic vaccines and used mRNA technology to help the immune system fight back.

Peanut allergies can be very serious, potentially resulting in life-threatening anaphylaxis. There could be new hope for eliminating such allergies, however, thanks to the use of peanut-packin' microneedles.

The latest results from a team developing treatments for peanut allergies have reaffirmed promising earlier findings, and also teased out new insights around the long-term treatment outcomes and how side effects might be kept to a minimum.

A comprehensive study from the UK has found that introducing children to certain foods at an early age is associated with a lower risk of developing allergies – and the correlation is clear even when subjects didn’t stick strictly to the regime.

Another promising potential treatment for peanut allergies has just emerged via a promising early trial at Stanford University, where scientists found an antibody treatment enabled those with severe allergies to stomach peanuts for some time.

The first oral immunotherapy agent to treat peanut allergy is set to be approved, but questions still remain over how effective and long-lasting it is.

A meta-analysis of a dozen trials into the efficacy of an oral immunotherapy treatment designed to reduce allergic reactions to peanuts has concluded the treatment may work in clinical environments but it also results in patients suffering from more real-world adverse allergic events.

A new oral desensitization treatment for children with peanut allergies is on the cusp of FDA approval, however questions remain over both the long-term efficacy of the treatment and the ultimate cost for what is essentially not that different to peanut flour in a capsule.

Rresearchers at the University of Michigan have found a way to retrain the immune system to ignore allergens by developing a nasal spray that vaccinates against peanut allergies, with promising results in mouse tests.